A team of infectious disease researchers has found via clinical trial that fecal transplants after kidney transplantation reduce the susceptibility of patients to infections by multi-drug-resistant organisms (MDROs). In their study, the group tested the impact of fecal microbiota transfer (FMT) on kidney transplant patients receiving care at Emory Transplant Center, in Atlanta. Prior research has shown that people who receive kidney transplantation are at risk of developing an infection from MDROs. This is because patients are given antibiotics to prevent general infections, killing all non-drug-resistant organisms. The absence of competing organisms allows MDROs to flourish, putting these patients at...
